PDCD1 and neoplasm: Significant activation-induced cell death of CAR-T cells was observed after repeated antigen stimulation, which was PD-1 dependent and PD-1 blockade could promote killing of PD-L1+ tumor cell lines and enhanced CAR-T cell survival in vitro.